Conventional vs. Drug-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma-A Propensity Score Weighted Comparison of Efficacy and Safety.

TACE drug-eluting beads hepatocellular carcinoma lipiodol outcome prognostic prediction propensity score analysis

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Nov 2022
Historique:
received: 18 10 2022
revised: 19 11 2022
accepted: 24 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 12 12 2022
Statut: epublish

Résumé

This study compared the efficacy and safety of conventional transarterial chemoembolization (cTACE) with drug-eluting beads (DEB)-TACE in patients with unresectable hepatocellular carcinoma (HCC). This retrospective analysis included 370 patients with HCC treated with cTACE (n = 248) or DEB-TACE (n = 122) (January 2000-July 2014). Overall survival (OS) was assessed using uni- and multivariate Cox proportional hazards models and Kaplan-Meier analysis. Additionally, baseline imaging was assessed, and clinical and laboratory toxicities were recorded. Propensity score weighting via a generalized boosted model was applied to account for group heterogeneity. There was no significant difference in OS between cTACE (20 months) and DEB-TACE patients (24.3 months, ratio 1.271, 95% confidence interval 0.876-1.69;

Identifiants

pubmed: 36497329
pii: cancers14235847
doi: 10.3390/cancers14235847
pmc: PMC9738175
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Korean J Radiol. 2014 Jul-Aug;15(4):464-71
pubmed: 25053906
Onkologie. 2011;34(7):368-76
pubmed: 21734423
Eur Radiol. 2016 Jun;26(6):1640-8
pubmed: 26455721
J Gastroenterol Hepatol. 2014 May;29(5):920-5
pubmed: 24224722
Eur Radiol. 2017 Feb;27(2):526-535
pubmed: 27277261
J Vasc Interv Radiol. 2011 Nov;22(11):1545-52
pubmed: 21849247
J Belg Soc Radiol. 2019 Jul 29;103(1):47
pubmed: 31531413
Cancer Treat Rev. 2019 Jan;72:28-36
pubmed: 30447470
Hepatol Res. 2015 Jan;45(2):190-200
pubmed: 25388603
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):39-62
pubmed: 15757804
Cardiovasc Intervent Radiol. 2020 Jan;43(1):55-64
pubmed: 31646378
J Gastroenterol Hepatol. 2017 Feb;32(2):487-496
pubmed: 27503585
World J Radiol. 2017 May 28;9(5):245-252
pubmed: 28634515
Cardiovasc Intervent Radiol. 2014 Apr;37(2):381-7
pubmed: 23754191
J Vasc Interv Radiol. 2020 Oct;31(10):1706-1716.e1
pubmed: 32684417
Life (Basel). 2022 Feb 16;12(2):
pubmed: 35207584
J Hepatol. 2011 Dec;55(6):1332-8
pubmed: 21703190
J Cancer Res Clin Oncol. 2013 Apr;139(4):635-43
pubmed: 23283527
Radiology. 2018 Dec;289(3):816-830
pubmed: 30251931
Trials. 2014 Aug 06;15:311
pubmed: 25095718
Cardiovasc Intervent Radiol. 2019 Nov;42(11):1551-1562
pubmed: 31321482
J Hepatol. 2012 Dec;57(6):1244-50
pubmed: 22824821
J Dig Dis. 2016 Aug;17(8):510-517
pubmed: 27384075
Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):75-85
pubmed: 27350573
Radiographics. 2015 Mar-Apr;35(2):371-86
pubmed: 25763723
J Vasc Interv Radiol. 2015 Apr;26(4):516-22
pubmed: 25704226
Ann Hepatol. 2021 May-Jun;22:100278
pubmed: 33129978
Eur Radiol. 2021 May;31(5):3002-3014
pubmed: 33063185
J Med Imaging Radiat Oncol. 2019 Dec;63(6):802-811
pubmed: 31709778
Hepat Med. 2016 Jun 20;8:69-74
pubmed: 27382341
J Hepatol. 2022 Mar;76(3):681-693
pubmed: 34801630
Liver Transpl. 2011 Oct;17 Suppl 2:S44-57
pubmed: 21695773
J Hepatocell Carcinoma. 2021 Aug 14;8:937-949
pubmed: 34422707
J Vasc Interv Radiol. 2013 Mar;24(3):301-6
pubmed: 23380737
Dig Liver Dis. 2016 Jun;48(6):571-7
pubmed: 26965785
World J Surg Oncol. 2018 Mar 27;16(1):69
pubmed: 29587773
J Hepatol. 2007 Mar;46(3):474-81
pubmed: 17239480
J Surg Oncol. 2010 May 1;101(6):476-80
pubmed: 20213741
Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52
pubmed: 19908093
Br J Cancer. 2014 Jul 15;111(2):255-64
pubmed: 24937669
J Vasc Interv Radiol. 2010 Mar;21(3):327-32
pubmed: 20097098
Cancers (Basel). 2020 Nov 17;12(11):
pubmed: 33212917
Cardiovasc Intervent Radiol. 2016 Mar;39(3):334-43
pubmed: 26390875
Liver Int. 2014 Feb;34(2):305-12
pubmed: 23890360

Auteurs

Lynn Jeanette Savic (LJ)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.
Department of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 10178 Berlin, Germany.

Evan Chen (E)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.

Nariman Nezami (N)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.
Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Experimental Therapeutics Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, USA.

Nikitha Murali (N)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.

Charlie Alexander Hamm (CA)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.
Department of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 10178 Berlin, Germany.

Clinton Wang (C)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.

MingDe Lin (M)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.

Todd Schlachter (T)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.

Kelvin Hong (K)

Division of Vascular and Interventional Radiology, Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA.

Christos Georgiades (C)

Division of Vascular and Interventional Radiology, Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA.

Julius Chapiro (J)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.

Fabian M Laage Gaupp (FM)

Section of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510, USA.

Classifications MeSH